What one share of Adma Biologics holds
We are a U.S. based end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases.
Adma Biologics’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $2.14 |
|---|---|
| Profit | $0.70 |
| Capex (buildings and equipment) | $0.08 |
| Free cash flow | $0.49 |
| Cash and investments | $0.60 |
| Debt | $0.87 |
| Book value | $1.81 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2011 | $2.16 | −$16.72 | — | — | — | $0.92 |
| 2012 | $0.21 | −$1.39 | $0.02 | −$1.33 | — | $1.61 |
| 2013 | $0.47 | −$2.38 | $0.03 | −$1.70 | — | $2.32 |
| 2014 | $0.64 | −$1.81 | $0.25 | −$1.83 | — | $0.65 |
| 2015 | $0.69 | −$1.73 | $0.00 | −$1.48 | — | $0.08 |
| 2016 | $0.88 | −$1.61 | $0.01 | −$1.51 | — | −$0.35 |
| 2017 | $0.99 | −$1.91 | $0.12 | −$1.74 | — | $1.10 |
| 2018 | $0.38 | −$1.45 | $0.05 | −$1.43 | — | $0.43 |
| 2019 | $0.54 | −$0.89 | $0.07 | −$1.47 | — | $0.44 |
| 2020 | $0.49 | −$0.88 | $0.15 | −$1.33 | — | $0.84 |
| 2021 | $0.58 | −$0.51 | $0.10 | −$0.90 | — | $0.72 |
| 2022 | $0.78 | −$0.33 | $0.07 | −$0.37 | — | $0.69 |
| 2023 | $1.15 | −$0.13 | $0.02 | $0.02 | — | $0.60 |
| 2024 | $1.75 | $0.81 | $0.03 | $0.45 | — | $1.48 |
| 2025 | $2.08 | $0.60 | $0.09 | $0.11 | — | $2.01 |
Common questions about Adma Biologics
How much does one share of Adma Biologics earn?
Over the last 12 months, each share of Adma Biologics earned $0.70 of profit on $2.14 of sales, keeping about 33¢ of every $1 (profit margin).
Does Adma Biologics pay a dividend?
Adma Biologics didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Adma Biologics’s book value per share?
Adma Biologics’s book value is $1.81 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Adma Biologics have?
Each share of Adma Biologics has $0.60 of cash and investments and $0.87 of debt, as of June 30, 2026.
What is Adma Biologics’s free cash flow per share?
$0.49 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Adma Biologics bought back shares?
Adma Biologics’s share count rose about 69259% from 2011 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.